HANSEN JOHN DAVID 4
4 · MABVAX THERAPEUTICS HOLDINGS, INC. · Filed Feb 23, 2018
Insider Transaction Report
Form 4
HANSEN JOHN DAVID
DirectorPresident and CEO
Transactions
- Award
Option to Purchase Common Stock
2018-02-21+290,000→ 290,000 totalExercise: $2.04Exp: 2028-02-21→ Common Stock (290,000 underlying)
Footnotes (2)
- [F1]Option award is partial compensation for service as an officer.
- [F2]The Option Shares shall vest 25% at the 6-month anniversary of the commencement date; with the balance vesting in equal monthly amounts of 4.167% per month over the remaining 18 months until fully vested after 2 years from the commencement date.